Frontiers in Clinical Drug Research – Anti infectives is a book series that brings up-to-date reviews to readers interested in learning more about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics, including the chemistry, pharmacology, molecular biology, and biochemistry of natural and synthetic drugs used in the treatment of infectious diseases. Reviews in this series also include research on multidrug resistance and preclinical/clinical findings on new antibiotics, vaccines, antifungal agents, and antituberculosis agents.
The eighth volume in this series presents comprehensive reviews of interest to readers interested in the treatment of inflammatory diseases, new antiviral agents and strategies, specific antiprotozoal drugs that work against leishmanias and helminths, and a study of agents against American foulbrood in honey bees.
The 7 journals included in this volume are:
– Monoclonal antibodies as therapeutic agents for inflammatory diseases
– Pharmacotherapy of emerging antiviral agents
– Antiviral activity of vitamin D and COVID-19: current understanding
– Anti-infective to fight leishmaniasis
– Discovery of anthelmintic drugs: current situation and future prospects
– Therapeutic targets of emerging Zika virus infection and vaccines in clinical trials
– Agro-industrial waste: new source of raw material for the control of American foulbrood in honey bees
Audience: Pharmaceutical scientists, physicians, virologists, entomologists, epidemiologists
About the publisher:
Atta-ur-Rahman, FRS, Ph.D. in Organic Chemistry from the University of Cambridge (1968) has 1,232 international publications (45 international patents and 341 books). He has received the following distinctions: Fellow Royal Society (FRS) London (2006), UNESCO Science Prize (1999), Honorary Life Fellow Kings College, Cambridge University (2007), Academician (Foreign Member) Chinese Academy of Sciences (2015), Highest Civil Award for Foreigners from China (Friendship Award, 2014), High Civil Award Austria (“Grosse Goldene Ehrenzeischen am Bande”) (2007), Foreign Fellow Chinese Chemical Society (2013), Sc. D. Cambridge University (UK) (1987), TWAS Prize (Italy) (2009). He was President of Network of Academies of Sciences of Islamic Countries (NASIC), Vice President of TWAS (Italy), Foreign Member of Korea Academy of Science and Technology, President of Pakistan Academy of Sciences (2003-2006 ) and (2011 – 2014). He served as Federal Minister of Science and Technology of Pakistan (2000-2002), Federal Minister of Education (2002) and Chairman of Higher Education Commission/Federal Minister (2002-2008), General Coordinator of COMSTECH (ministerial committee 01C) (1996-2012) and editor of Current Medicinal Chemistry.
Chemotherapy, Immunomodulators, Host protein targets, Molecular pathogenesis, Zika virus, Beta coronavirus, Calcidiol, Biopharmaceutical market, Inflammatory diseases, Monoclonal antibodies, Therapeutic agents.
For more information, please visit: https://bit.ly/3pCcTlC
Warning: AAAS and EurekAlert! are not responsible for the accuracy of press releases posted on EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.